BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29533018)

  • 1. Androgen receptor as a prognostic biomarker and therapeutic target in uterine leiomyosarcoma.
    Baek MH; Park JY; Park Y; Kim KR; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    J Gynecol Oncol; 2018 May; 29(3):e30. PubMed ID: 29533018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone Receptor Expression Is an Independent Prognosticator in FIGO Stage I Uterine Leiomyosarcoma.
    Davidson B; Kjæreng ML; Førsund M; Danielsen HE; Kristensen GB; Abeler VM
    Am J Clin Pathol; 2016 Apr; 145(4):449-58. PubMed ID: 27149024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma.
    Leitao MM; Soslow RA; Nonaka D; Olshen AB; Aghajanian C; Sabbatini P; Dupont J; Hensley M; Sonoda Y; Barakat RR; Anderson S
    Cancer; 2004 Sep; 101(6):1455-62. PubMed ID: 15316901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers.
    Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
    Tumour Biol; 2011 Jun; 32(3):451-9. PubMed ID: 21161468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor expression in male breast cancer predicts inferior outcome and poor response to tamoxifen treatment.
    Wenhui Z; Shuo L; Dabei T; Ying P; Zhipeng W; Lei Z; Xiaohui H; Jingshu G; Hongtao S; Qingyuan Z
    Eur J Endocrinol; 2014 Oct; 171(4):527-33. PubMed ID: 25069458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen and progesterone receptors expression in uterine malignant smooth muscle tumors: correlation with clinical outcome.
    Raspollini MR; Amunni G; Villanucci A; Boddi V; Simoni A; Taddei A; Taddei GL
    J Chemother; 2003 Dec; 15(6):596-602. PubMed ID: 14998087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selected biomarker analysis in 5 types of uterine smooth muscle tumors.
    Zhang Q; Kanis MJ; Ubago J; Liu D; Scholtens DM; Strohl AE; Lurain JR; Shahabi S; Kong B; Wei JJ
    Hum Pathol; 2018 Jun; 76():17-27. PubMed ID: 29258902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of estrogen and progesterone receptors and outcomes in patients with newly diagnosed uterine leiomyosarcoma.
    Leitao MM; Hensley ML; Barakat RR; Aghajanian C; Gardner GJ; Jewell EL; O'Cearbhaill R; Soslow RA
    Gynecol Oncol; 2012 Mar; 124(3):558-62. PubMed ID: 22085894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of hormone receptor expression and its prognostic value in endometrial stromal sarcoma.
    Park JY; Baek MH; Park Y; Kim YT; Nam JH
    Virchows Arch; 2018 Jul; 473(1):61-69. PubMed ID: 29869299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of tumor size as staging variable in the revised International Federation of Gynecology and Obstetrics stage I leiomyosarcoma: a population-based study.
    Garg G; Shah JP; Liu JR; Bryant CS; Kumar S; Munkarah A; Morris RT
    Int J Gynecol Cancer; 2010 Oct; 20(7):1201-6. PubMed ID: 20940535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of progesterone receptor, p16, p53 and pHH3 expression in uterine atypical leiomyoma.
    Liang Y; Zhang X; Chen X; Lü W
    Int J Clin Exp Pathol; 2015; 8(6):7196-202. PubMed ID: 26261614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes and prognostic markers in uterine leiomyosarcoma: a population-based cohort.
    Garcia C; Kubat JS; Fulton RS; Anthony AT; Combs M; Powell CB; Littell RD
    Int J Gynecol Cancer; 2015 May; 25(4):622-8. PubMed ID: 25675041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myxoid Leiomyosarcoma of the Uterus: A Clinicopathologic Analysis of 30 Cases and Review of the Literature With Reappraisal of Its Distinction From Other Uterine Myxoid Mesenchymal Neoplasms.
    Parra-Herran C; Schoolmeester JK; Yuan L; Dal Cin P; Fletcher CD; Quade BJ; Nucci MR
    Am J Surg Pathol; 2016 Mar; 40(3):285-301. PubMed ID: 26866354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FIGO staging for uterine sarcomas: can the revised 2008 staging system predict survival outcome better?
    Yim GW; Nam EJ; Kim SW; Kim YT
    Yonsei Med J; 2014 May; 55(3):563-9. PubMed ID: 24719120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study.
    Akhan SE; Yavuz E; Tecer A; Iyibozkurt CA; Topuz S; Tuzlali S; Bengisu E; Berkman S
    Gynecol Oncol; 2005 Oct; 99(1):36-42. PubMed ID: 15992918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
    Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
    Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    de Almeida BC; Dos Anjos LG; Uno M; Cunha IWD; Soares FA; Baiocchi G; Baracat EC; Carvalho KC
    Cells; 2019 Nov; 8(11):. PubMed ID: 31744257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and progesterone receptor expression in patients with uterine leiomyosarcoma and correlation with different clinicopathological parameters.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K
    Anticancer Res; 2003; 23(1B):729-32. PubMed ID: 12680175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma.
    Park JY; Park SK; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2011 Aug; 122(2):255-9. PubMed ID: 21565389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex.
    Berardi R; Morgese F; Santinelli A; Onofri A; Biscotti T; Brunelli A; Caramanti M; Savini A; De Lisa M; Ballatore Z; Pompili C; Salati M; Mazzanti P; Torniai M; Cascinu S
    Oncotarget; 2016 Dec; 7(50):82648-82657. PubMed ID: 27690341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.